½ÃÀ庸°í¼­
»óǰÄÚµå
1624389

¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ ½ºÅ©¸®´×/ÄÝ·¹½ºÅ×·Ñ ½ÇÇè½Ç °Ë»ç ¼­ºñ½º ½ÃÀå ±Ô¸ð : °í°´ À¯Çüº°, Áö¿ªº°, ¹üÀ§ ¹× ¿¹Ãø

Global Cholesterol Screening/Cholesterol Lab Testing Services Market Size By Type Of Customer, By Competitive Landscape, By Geography Scope And Forecast

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Verified Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 202 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÄÝ·¹½ºÅ×·Ñ °Ë»ç/ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼­ºñ½º ½ÃÀå ±Ô¸ð ¹× Àü¸Á

ÄÝ·¹½ºÅ×·Ñ °Ë»ç/ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼­ºñ½º ½ÃÀå ±Ô¸ð´Â 2020³â 154¾ï ´Þ·¯·Î Æò°¡µÇ¸ç 2021-2028³â ¿¬Æò±Õ 7.9% ¼ºÀåÇÏ¿© 2028³â¿¡´Â 286¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÉÇ÷°ü Áúȯ ¹× ºñ¸¸ À¯º´·ü Áõ°¡, ÀÚ°¡ °Ë»çº¸´Ù ½ÇÇè½Ç °Ë»ç¸¦ ¼±È£ÇÏ´Â ÀÇ»ç, °Ë»ç ǰÁú Çâ»óÀ» À§ÇÑ Á¤ºÎÀÇ ±¸»ó, ³ëÀÎ Àα¸ÀÇ ±Þ¼ÓÇÑ Áõ°¡´Â ÄÝ·¹½ºÅ×·Ñ °Ë»ç/ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÄÝ·¹½ºÅ×·Ñ °Ë»ç/ÄÝ·¹½ºÅ×·Ñ °Ë»ç/ÄÝ·¹½ºÅ×·Ñ ½ÇÇè½Ç °Ë»ç ¼­ºñ½º ¼¼°è ½ÃÀå º¸°í¼­´Â ½ÃÀåÀÇ Àü¹ÝÀûÀÎ Æò°¡¸¦ Á¦°øÇÕ´Ï´Ù. ÁÖ¿ä ºÎ¹®, µ¿Çâ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, °æÀï ±¸µµ ½ÃÀå¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ¿äÀÎ µîÀ» Á¾ÇÕÀûÀ¸·Î ºÐ¼®ÇÕ´Ï´Ù.

ÄÝ·¹½ºÅ×·Ñ °Ë»ç/ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼­ºñ½º ¼¼°è ½ÃÀå Á¤ÀÇ

ºñȰµ¿ÀûÀÎ »ýȰ½À°üÀÇ È®»êÀ¸·Î Àü ¼¼°è¿¡¼­ ÄÝ·¹½ºÅ×·Ñ °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÄÝ·¹½ºÅ×·ÑÀº ¿Î½º °°Àº Áö¹æ°ú °°Àº ¹°Áú·Î Ç÷·ù, ½Å°æ¼¶À¯, ü³» Àå±â¿¡ Á¸ÀçÇÕ´Ï´Ù. »ç¶÷ÀÇ ÄÝ·¹½ºÅ×·Ñ ¼öÄ¡´Â À¯Àü, µ¿¹°¼º ½Äǰ°ú °°Àº Æ÷È­Áö¹æ»êÀÌ ¸¹Àº À½½Ä ¼·Ãë, ´ç´¢º´°ú °°Àº ´ë»ç¼º Áúȯ, ³ªÀÌ, ¼ºº° µîÀÇ ¿äÀο¡ ÀÇÇØ °áÁ¤µË´Ï´Ù.

ÄÝ·¹½ºÅ×·Ñ °Ë»ç/ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼­ºñ½º ¼¼°è ½ÃÀå °³¿ä

ÄÝ·¹½ºÅ×·Ñ ¼öÄ¡°¡ »ó½ÂÇÏ¸é ³úÁ¹Áß°ú ½ÉÀ庴ÀÇ À§ÇèÀÌ ³ô¾ÆÁö´Â µî °Ç°­»óÀÇ À§ÇèÀÌ Áõ°¡ÇÏ¿© ¸¹Àº »ç¸Á¿øÀÎÀÌ µË´Ï´Ù. ÄÝ·¹½ºÅ×·Ñ ½ÇÇè½Ç °Ë»ç´Â ¹®Á¦¸¦ Á¶±â¿¡ ¹ß°ßÇϰí ÇÕº´ÁõÀ» ÇÇÇϸç ȯÀÚÀÇ »ýÁ¸ °¡´É¼ºÀ» ³ôÀÏ ¼ö ÀÖÀ¸¸ç, ÄÝ·¹½ºÅ×·Ñ °Ë»ç/ÄÝ·¹½ºÅ×·Ñ ½ÇÇè½Ç °Ë»ç ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀÔ´Ï´Ù.

½ÃÀå ¼ºÀåÀÇ ´Ù¸¥ Áß¿äÇÑ ÃËÁø¿äÀÎÀ¸·Î´Â ÄÝ·¹½ºÅ×·ÑÀÇ À§Ç輺¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡¿Í ÀÌ·¯ÇÑ °Ë»çÀÇ Á߿伺¿¡ ´ëÇÑ ±³À°, ½ÉÇ÷°ü Áúȯ, ³úÁ¹Áß ¹× ±âŸ ½ÉÀåÁúȯÀÇ ÀÌȯÀ² Áõ°¡, ÀÇ·áºñ ÁöÃâ Áõ°¡, Á¤ºÎÀÇ ±¸»ó, ³ëÀÎ Àα¸ Áõ°¡ ¹× ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼­ºñ½ºÀÇ ±â¼ú ¹ßÀü, °úÀÏ, ÆÐ½ºÆ®Çªµå, ÆÐ½ºÆ®Çªµå ¼±È£, ¿îµ¿ ºÎÁ· µîÀÌ ÀÖ½À´Ï´Ù. °úÀÏ ¹× ä¼Ò ¼Òºñ °¨¼Ò, ÆÐ½ºÆ®Çªµå ¼±È£ µî °Ç°­¿¡ ÇØ·Î¿î ½Ä½À°ü, ¿îµ¿ ºÎÁ· µîÀÌ ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

ºñ¸¸µµ °íÄÝ·¹½ºÅ׷Ѱú °ü·ÃµÈ Áõ»ó Áß ÇϳªÀÔ´Ï´Ù. ÄÝ·¹½ºÅ×·Ñ·Î ÀÎÇÑ Áúº´ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ °Ë»ç¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼¼°è ½ÇÇè½Ç ÄÝ·¹½ºÅ×·Ñ °Ë»ç ½ÃÀåÀº È®´ëµÉ °ÍÀÔ´Ï´Ù. ±×·¯³ª ºñħ½ÀÀû ÄÝ·¹½ºÅ×·Ñ °Ë»ç¹ýÀÇ µµÀÔÀ¸·Î ÀÎÇÑ Á¦ÇѰú ´õºÒ¾î °¡Á¤¿ë ¶Ç´Â ÀÚ°¡ °Ë»ç ŰƮÀÇ Á¸Àç´Â ¼ºÀåÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ ½ºÅ©¸®´×/ÄÝ·¹½ºÅ×·Ñ ½ÇÇè½Ç °Ë»ç ¼­ºñ½º ½ÃÀå : ¼­·Ð

  • ½ÃÀå °³¿ä
  • Á¶»ç ¹üÀ§
  • ÀüÁ¦Á¶°Ç

Á¦2Àå °³¿ä

Á¦3Àå VERIFIED MARKET RESEARCHÀÇ Á¶»ç ¹æ¹ý

  • µ¥ÀÌÅÍ ¸¶ÀÌ´×
  • ¹ë¸®µ¥À̼Ç
  • 1Â÷ ÀÚ·á
  • µ¥ÀÌÅÍ ¼Ò½º ¸®½ºÆ®

Á¦4Àå ¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ ½ºÅ©¸®´×/ÄÝ·¹½ºÅ×·Ñ ½ÇÇè½Ç °Ë»ç ¼­ºñ½º ½ÃÀå Àü¸Á

  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • Porter's Five Forces ¸ðµ¨
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ ½ºÅ©¸®´×/ÄÝ·¹½ºÅ×·Ñ ½ÇÇè½Ç °Ë»ç ¼­ºñ½º ½ÃÀå : °í°´ À¯Çüº°

  • °³¿ä
  • ÀÇ»ç/ÇÁ·Î¹ÙÀÌ´õ ¹× º´¿ø
  • Á¤ºÎ±â°ü
  • Áø´Ü ¼¾ÅÍ
  • ȯÀÚ
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ ½ºÅ©¸®´×/ÄÝ·¹½ºÅ×·Ñ ½ÇÇè½Ç °Ë»ç ¼­ºñ½º ½ÃÀå : Áö¿ªº°

  • °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¼¼°èÀÇ ±âŸ Áö¿ª
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦7Àå ¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ ½ºÅ©¸®´×/ÄÝ·¹½ºÅ×·Ñ ½ÇÇè½Ç °Ë»ç ¼­ºñ½º ½ÃÀå : °æÀï ±¸µµ

  • °³¿ä
  • ±â¾÷ ½ÃÀå Á¡À¯À²
  • º¥´õ ±¸µµ
  • ÁÖ¿ä ¹ßÀü Àü·«

Á¦8Àå ±â¾÷ °³¿ä

  • Laboratory Corporation of America Holdings(LabCorp)
  • Quest Diagnostics Incorporated
  • Eurofins Scientific
  • Spectra Laboratories, Inc.
  • Unilabs
  • Synlab International GmbH
  • Bio-Reference Laboratories, Inc.
  • Clinical Reference Laboratory, Inc.
  • ACM Medical Laboratory
  • Adicon Clinical Laboratory

Á¦9Àå ºÎ·Ï

  • °ü·Ã ¸®Æ÷Æ®
KSA 25.02.05

Cholesterol Screening/Cholesterol Lab Testing Services Market Size And Forecast

Cholesterol Screening/Cholesterol Lab Testing Services Market size was valued at USD 15.4 Billion in 2020 and is projected to reachUSD 28.6 Billion by 2028, growing at aCAGR of 7.9% from 2021 to 2028.

The increased incidence of cardiovascular disease and obesity, doctors' preference for laboratory testing over self-testing, government initiatives to improve test quality, and the rapid growth of the geriatric population are driving the growth of the Cholesterol Screening/Cholesterol Lab Testing Services Market. The Global Cholesterol Screening/Cholesterol Lab Testing Services Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cholesterol Screening/Cholesterol Lab Testing Services Market Definition

The pervasiveness of inactive lifestyles is expected to increase the demand for cholesterol laboratory tests around the world. Cholesterol is a waxy, fat-like substance that is present in the bloodstream, in nerve fibers, and body organs. A person's cholesterol level is determined by factors such as heredity, consumption of foods high in saturated fatty acids like animal products, and metabolic diseases such as diabetes, age, and gender.

Global Cholesterol Screening/Cholesterol Lab Testing Services Market Overview

Elevated cholesterol level increases health risks such as a high risk of stroke and heart disease, which are responsible for a large number of deaths. Cholesterol laboratory tests enable problems to be detected early, avoid complications and increase the patient's chances of survival which drives the growth of the Cholesterol Screening/Cholesterol Lab Testing Services Market.

Other important drivers of market growth are the gradual awareness of the dangers of cholesterol and education about the importance of these tests, the increasing incidence of cardiovascular diseases, strokes, and other heart diseases, the growth in health care spending, government initiatives, the increase in the geriatric population and technological advances in cholesterol laboratory testing services, low consumption of fruits and vegetables, unhealthy food habits such as liking for fast food and fast food, and lack of physical inactivity have fueled the growth of this market.

Obesity is another condition related to high cholesterol. As the number of cholesterol-induced diseases increases, so will the need for these tests, expanding the market for global laboratory cholesterol testing. However, the presence of home or self-test kits could restrict the growth in addition to the limitations imposed by the introduction of non-invasive cholesterol testing procedures.

Global Cholesterol Screening/Cholesterol Lab Testing Services Market Segmentation Analysis

The Global Cholesterol Screening/Cholesterol Lab Testing Services Market is Segmented on the basis of Type of Customer And Geography.

Cholesterol Screening/Cholesterol Lab Testing Services Market, By Type Of Customer

  • Physicians/Providers and Hospitals
  • Government Agencies
  • Diagnostic centers
  • Patients
  • Others

Based on Type Of Customer, The market is segmented into Physicians/Providers and Hospitals, Government Agencies, Diagnostic centers, Patients, and Others. Diagnostic Centres dominated the market in terms of total revenue share and are also expected to have the fastest CAGR during the forecast period due to the increasing number of people diagnosed with high total cholesterol. Furthermore, regular health checkups without the doctors' Interventions are also a powerful driver of growth. The Government segment is expected to experience significant growth in the forecast period due to its increasing focus on prevention and early detection to avoid serious illnesses.

Cholesterol Screening/Cholesterol Lab Testing Services Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, The Global Cholesterol Screening/Cholesterol Lab Testing Services Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is expected to dominate the global Cholesterol Screening/Cholesterol Lab Testing Services Market, with the United States having a significant share. Asia is projected to be the fastest-growing region in terms of CAGR. Due to the large population base, increased prevalence of cardiovascular disease, and a growing number of testing facilities in the Asia region over the forecast period.

Key Players

  • The "Global Cholesterol Screening/Cholesterol Lab Testing Services Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
  • Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Spectra Laboratories, Inc., Unilabs, Synlab International GmbH, Bio-Reference Laboratories, Inc., Clinical Reference Laboratory, Inc., ACM Medical Laboratory, and Adicon Clinical Laboratory.
  • The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CHOLESTEROL SCREENING/CHOLESTEROL LAB TESTING SERVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CHOLESTEROL SCREENING/CHOLESTEROL LAB TESTING SERVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL CHOLESTEROL SCREENING/CHOLESTEROL LAB TESTING SERVICES MARKET, BY TYPE OF CUSTOMER

  • 5.1 Overview
  • 5.2 Physicians/Providers and Hospitals
  • 5.3 Government Agencies
  • 5.4 Diagnostic centers
  • 5.5 Patients
  • 5.6 Others

6 GLOBAL CHOLESTEROL SCREENING/CHOLESTEROL LAB TESTING SERVICES MARKET, BY GEOGRAPHY

  • 6.1 Overview
  • 6.2 North America
    • 6.2.1 U.S.
    • 6.2.2 Canada
    • 6.2.3 Mexico
  • 6.3 Europe
    • 6.3.1 Germany
    • 6.3.2 U.K.
    • 6.3.3 France
    • 6.3.4 Rest of Europe
  • 6.4 Asia Pacific
    • 6.4.1 China
    • 6.4.2 Japan
    • 6.4.3 India
    • 6.4.4 Rest of Asia Pacific
  • 6.5 Rest of the World
    • 6.5.1 Latin America
    • 6.5.2 Middle East & Africa

7 GLOBAL CHOLESTEROL SCREENING/CHOLESTEROL LAB TESTING SERVICES MARKET COMPETITIVE LANDSCAPE

  • 7.1 Overview
  • 7.2 Company Market Share
  • 7.3 Vendor Landscape
  • 7.4 Key Development Strategies

8 COMPANY PROFILES

  • 8.1 Laboratory Corporation of America Holdings (LabCorp)
    • 8.1.1 Overview
    • 8.1.2 Financial Performance
    • 8.1.3 Product Outlook
    • 8.1.4 Key Developments
  • 8.2 Quest Diagnostics Incorporated
    • 8.2.1 Overview
    • 8.2.2 Financial Performance
    • 8.2.3 Product Outlook
    • 8.2.4 Key Developments
  • 8.3 Eurofins Scientific
    • 8.3.1 Overview
    • 8.3.2 Financial Performance
    • 8.3.3 Product Outlook
    • 8.3.4 Key Developments
  • 8.4 Spectra Laboratories, Inc.
    • 8.4.1 Overview
    • 8.4.2 Financial Performance
    • 8.4.3 Product Outlook
    • 8.4.4 Key Developments
  • 8.5 Unilabs
    • 8.5.1 Overview
    • 8.5.2 Financial Performance
    • 8.5.3 Product Outlook
    • 8.5.4 Key Developments
  • 8.6 Synlab International GmbH
    • 8.6.1 Overview
    • 8.6.2 Financial Performance
    • 8.6.3 Product Outlook
    • 8.6.4 Key Developments
  • 8.7 Bio-Reference Laboratories, Inc.
    • 8.7.1 Overview
    • 8.7.2 Financial Performance
    • 8.7.3 Product Outlook
    • 8.7.4 Key Developments
  • 8.8 Clinical Reference Laboratory, Inc.
    • 8.8.1 Overview
    • 8.8.2 Financial Performance
    • 8.8.3 Product Outlook
    • 8.8.4 Key Developments
  • 8.9 ACM Medical Laboratory)
    • 8.9.1 Overview
    • 8.9.2 Financial Performance
    • 8.9.3 Product Outlook
    • 8.9.4 Key Developments
  • 8.10 Adicon Clinical Laboratory
    • 8.10.1 Overview
    • 8.10.2 Financial Performance
    • 8.10.3 Product Outlook
    • 8.10.4 Key Developments

9 Appendix

  • 9.1 Related Reports
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦